Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)

Completed · Phase 3

Conditions studied: Alopecia

In brief

Clinical alopecia occurs due to miniaturization of the hair shafts as well as loss of active production of hair shafts. PRFM has been shown to induce dermal angiogenesis, and anecdotal findings of improvement of hair appearance after PRFM injection in the scalp suggest that PRFM may play a role in the treatment of thinning hair. Patients will be treated on a monthly basis with intradermal injections of autologous PRFM for 3 months. Changes in hair density will be assessed by comparing pre- and post-treatment photographs and non-invasive measurements of hair density at 1, 2, 3, 4 and 6 months after initial treatment.

Key facts

Study ID

NCT01590238

Run by

The New York Eye & Ear Infirmary

People needed

15

Starts

2012-05-01

Expected to finish

2013-11-01

Last updated by the study team

2017-02-15

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• age 18- 75 years old
• frontal and/or crown alopecia

You may not qualify if…

• bleeding disorder

Where it is running

• The New York Eye & Ear Infirmary — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.